Forensics News and Research

RSS

Gray Healthcare's new community recovery model benefits users in the least restrictive environment

Gray Healthcare has appointed former director of operations of Cambian healthcare Noel Tracey to lead its expanding Community Recovery Team, as Clinical Director.

2 Feb 2010

Thermo Fisher Scientific to acquire Finnzymes

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Finnzymes, a well-recognized provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. Headquartered in Espoo, Finland, Finnzymes has 90 employees and generated revenue of $20 million in 2009.

From Thermo Fisher Scientific Inc. 2 Feb 2010

Diabetes journal reviews the role of hypoglycemia in criminal behavior

Professor Vincent Marks, a leading authority on the forensic aspects of hypoglycemia and its role in criminal behavior, discusses how hypoglycemia-related neuroglycopenia can cause behavioral changes, which can bring people with diabetes into conflict with the law. "

31 Jan 2010

BIA to exhibit new in-house software platform at 2010 Legaltech conference

Business Intelligence Associates, Inc. (BIA), a legal software and services industry leader, announced today that they will be exhibiting their new in-house ESI Management software product, Solis™, at ALM's LegalTech® New York 2010 from February 1-3, 2010 (Booth #1720).

30 Jan 2010

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Rubicon Genomics, Inc., a developer of pre-analytical amplification products that enable more comprehensive genetic analysis of clinical and research samples, announced today that it has reached agreement with ZyGEM to non-exclusively market Rubicon's PicoPlex™ single-cell amplification kits in Australia and New Zealand.

30 Jan 2010

OMT, a viable option for treating back pain in the third trimester of pregnancy

For many pregnant women, it's inevitable. As their pregnancy progresses, tasks that involve the low back often get more difficult. It is harder to bend over, lift, sit or walk for long periods of time, and back pain increases. Treating back pain, and improving daily function relative to tasks that involve the low back is a challenge because pregnant women are limited to treatments that will not create problems for their developing baby.

29 Jan 2010

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Life Technologies Corporation today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increase of 5 percent over the $3.14 billion reported for 2008, as if Invitrogen and Applied Biosystems had been combined.

From Danaher 28 Jan 2010

Over 8% of medical devices in circulation are counterfeit: WHO

Counterfeit medical products are becoming an international epidemic. According to the World Health Organization (WHO), more than 8% of the medical devices in circulation are counterfeit. The offending products may be assembled from inferior quality components, or worse yet, from fake parts that could contain toxic materials. In either case the dangers are the same. Counterfeit medical devices pose a significant liability to the manufacturers and a health risk to both the patients and healthcare providers that could result in injury, permanent disability, or even death.

28 Jan 2010

Applied Biosystems' AmpFℓSTR MiniFiler PCR Amplification Kit receives NDIS approval

Applied Biosystems, part of Life Technologies Corporation today announced that its AmpFℓSTR® MiniFiler™ PCR Amplification Kit has been approved for inclusion in the National DNA Index System (NDIS), a United States Federal Bureau of Investigation database that facilitates the electronic comparison and exchange of DNA profiles between participating local, county, state, and federal law enforcement agencies and forensic laboratories.

21 Jan 2010

WIREs Cognitive Science explores the rise of neurolaw

What if a jury could decide a man's guilt through mind reading? What if reading a defendant's memory could betray their guilt? And what constitutes 'intent' to commit murder? These are just some of the issues debated and reviewed in the inaugural issue of WIREs Cognitive Science, the latest interdisciplinary project from Wiley-Blackwell, which for registered institutions will be free for the first two years.

21 Jan 2010

DNA testing can help individuals make more-informed health and lifestyle decisions

Mention the term “genetic testing” and reactions can vary widely—from curiosity, to reticence or anxiety, to enthusiastic acceptance. The reality is, DNA testing has been used for decades, primarily to determine the paternity of children and to obtain forensic evidence for police investigations and legal trials.

20 Jan 2010

Sudden deaths attributed to cocaine use; drug remains a growing health problem in Europe

Forensic pathologists have shown that over three per cent of all sudden deaths in south-west Spain are related to the use of cocaine. They believe their findings can be extrapolated to much of the rest of Europe, indicating that cocaine use is a growing public health problem in Europe and that there is no such thing as "safe" recreational use of small amounts of the drug.

13 Jan 2010

Interest in studying psychology on the rise

"I hope I will be able to touch the lives of people when they most need help and to offer them advice and guidance."

9 Jan 2010

NCC Construction Sweden to build new forensic psychiatric care facility in Gothenburg

NCC Construction Sweden has been commissioned to construct a new forensic psychiatric care facility in Olofstorp, 15 kilometers north-east of Gothenburg, Sweden. The client is Västfastigheter and the order value is slightly more than SEK 500 million.

7 Jan 2010

Medical treatment and evacuation during international travel

Recent surveys indicate that international travel, which had fallen off substantially over the course of the global recession, has rebounded in recent months – which means more U.S. business and leisure travelers navigating health- and security-related risks out in foreign corners of the world.

28 Dec 2009

Infecting mosquitoes with Wolbachia bacteria increases their resistance to human disease-causing viruses

Earlier this year, researchers showed that they could cut the lives of disease-carrying mosquitoes in half by infecting them with a bacterium they took from fruit flies. Now, a new report in the December 24th issue of Cell, a Cell Press publication, suggests that their strategy might do one better: The Wolbachia bacteria also makes the mosquitoes more resistant to infection by viruses that are a growing threat to humans, including those responsible for dengue fever and Chikungunya.

28 Dec 2009

Neogen reports record net income for second-quarter fiscal 2010

Neogen Corporation announced today that its net income for the second quarter of FY 2010, which ended Nov. 30, increased 18% from the previous year's second quarter. Adjusted for a 3-for-2 stock split effective Dec. 15, net income in the quarter rose to $0.20 per share, compared to the prior year's $0.17. Neogen's second quarter net income of $4,610,000 set another quarterly record for the 27-year-old company.

19 Dec 2009

Biotage expands direct sales coverage

Biotage is expanding its direct sales coverage and will begin selling SPE products directly into non-pharma application areas within the UK starting January 18, 2010. Sales to non-pharmaceutical based markets and customers have previously been managed by a distributor.

16 Dec 2009

Italian patent issued for NPM1 to test patients with AML

Xenomics, Inc., a developer of transrenal molecular diagnostics, announced today that a key Italian patent covering a unique diagnostic application with critical significance for patients with acute myeloid leukemia (AML) has issued.